Microbiological recovery studies used to validate the swab testing method used in cleaning validation are inadequate.
Inspection Record
GenTrac, Inc. — FDA 483 Findings
Inspectors Lizaida Perez · Peng ZhouThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
(b) (4) identified on equipment product contact surfaces is not characterized nor its potential impact to drug substance quality assessed.
Procedures regarding segregation of duties are inadequately defined or not always followed in the Quality Unit.
Training and qualification related to laboratory operations are not adequately documented or implemented and associated corrective actions are not demonstrated to be effective.
A record as of the US FDA document published on 2026-10-27. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.